Syntaxin 1 is a crucial component of the cellular machinery involved in vesicle trafficking, particularly in the nervous system. As a member of the SNARE (Soluble N-ethylmaleimide-sensitive factor Attachment protein REceptor) protein family, Syntaxin 1 plays a fundamental role in the docking and fusion of synaptic vesicles with the presynaptic membrane, a process essential for neurotransmitter release. This protein is primarily located in the presynaptic plasma membrane of neurons, where it forms a complex with other SNARE proteins, such as SNAP-25 and VAMP (vesicle-associated membrane protein). The formation of this SNARE complex is critical for bringing the vesicle and plasma membranes into close proximity, facilitating membrane fusion and the subsequent release of neurotransmitters into the synaptic cleft. Syntaxin 1 is involved in the regulation of neurotransmitter release, which is a key process in neuronal communication and synaptic plasticity. The protein's structure is such that it includes a transmembrane domain, a SNARE domain, and a regulatory H3 domain, which is crucial for its interaction with Munc18, a protein that regulates SNARE complex formation. Syntaxin 1's ability to interact with multiple proteins and its involvement in a variety of protein-protein interactions underscore its pivotal role in the highly coordinated process of synaptic vesicle exocytosis.
The inhibition of Syntaxin 1 affects the regulation of neurotransmitter release, impacting neuronal communication. Several mechanisms have been identified through which Syntaxin 1 activity can be modulated or inhibited. One primary method involves the alteration of its interaction with other SNARE proteins or regulatory molecules. For instance, proteins or compounds that bind to the SNARE or H3 domains of Syntaxin 1 can hinder the formation of the SNARE complex, thereby inhibiting vesicle docking and fusion. Another mechanism of inhibition could be the post-translational modification of Syntaxin 1, such as phosphorylation, which can alter its conformation or its affinity for other SNARE proteins, impacting the formation of the SNARE complex. Additionally, the interaction of Syntaxin 1 with other regulatory proteins like Munc18 is crucial for its function. Modulation of this interaction, either by altering Munc18 or by affecting the binding interface between Syntaxin 1 and Munc18, can also serve as a mechanism to regulate or inhibit Syntaxin 1 activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
N-Ethylmaleimide | 128-53-0 | sc-202719A sc-202719 sc-202719B sc-202719C sc-202719D | 1 g 5 g 25 g 100 g 250 g | $22.00 $69.00 $214.00 $796.00 $1918.00 | 19 | |
Alkylates cysteine residues and can disrupt protein interactions involving Syntaxin 1 by modifying its SNARE motif, inhibiting its ability to form complexes. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
A dynamin inhibitor that impairs clathrin-mediated endocytosis and may indirectly affect Syntaxin 1 recycling and function. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
An ionophore that disrupts intracellular ion gradients and can lead to alterations in vesicle trafficking, potentially affecting Syntaxin 1's role in vesicle fusion. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Inhibits ADP-ribosylation factor (ARF), leading to disruption of vesicular transport and potentially altering Syntaxin 1 localization and function. | ||||||
Pitstop 2 | 1419320-73-2 | sc-507418 | 10 mg | $360.00 | ||
Blocks clathrin-mediated endocytosis, potentially leading to accumulation of synaptic vesicles and altered Syntaxin 1 dynamics. | ||||||
Concanamycin A | 80890-47-7 | sc-202111 sc-202111A sc-202111B sc-202111C | 50 µg 200 µg 1 mg 5 mg | $66.00 $167.00 $673.00 $2601.00 | 109 | |
V-ATPase inhibitor that prevents acidification of vesicles, possibly affecting the vesicle priming process where Syntaxin 1 is involved. | ||||||
SecinH3 | 853625-60-2 | sc-203260 | 5 mg | $278.00 | 6 | |
Inhibits cytohesins, disrupting ARF function and potentially affecting the subcellular distribution and activity of Syntaxin 1. | ||||||